Pharmagen Healthcare Limited

What Pharmagen Healthcare Limited does

Pharmagen Healthcare Limited (legal name: Pharmagen Limited) is a Pakistani Active Pharmaceutical Ingredient (API) manufacturer founded on 24 November 1990 by a group of pharmaceutical industry professionals, and incorporated as a Public Limited Non-Quoted Company in Pakistan. The company operates four dedicated, physically separated production plants at a manufacturing site near Lahore: semi-synthetic penicillins (operational since 1993), oral semi-synthetic cephalosporins (since 2000), sterile semi-synthetic cephalosporins (since 2006), and a multi-purpose general products plant (since 2014), with combined annual API output of approximately 1,300 tons. Pharmagen produces 21 distinct API molecules spanning penicillins (amoxicillin, ampicillin, cloxacillin, flucloxacillin), cephalosporins (cephradine, cephalexin, cefixime, cefadroxil, cefaclor, ceftriaxone sodium, cefotaxime sodium), anti-diabetics (sitagliptin, vildagliptin, empagliflozin, dapagliflozin), and analgesics/antipyretics/antibacterials (paracetamol, ibuprofen, ciprofloxacin, moxifloxacin), all meeting BP, USP, and EP pharmacopoeial standards where applicable.

All facilities are cGMP compliant, hold the A-grade plant rating from Pakistan's Drug Regulatory Authority (DRAP), and are certified to ISO 9001:2015 (quality), ISO 14001:2015 (environment), ISO 45001:2018 (occupational health and safety), and ISO/IEC 17025:2017 (laboratory competence). The company runs an in-house R&D team of PhDs focused on process improvement and operates a proprietary bio-cleaning wastewater treatment system described as unique among Pakistani pharmaceutical plants.

Pharmagen operates a B2B model with direct field sales to pharmaceutical manufacturers, serving 350+ customers across Pakistan, including globally approved multinational buyers such as GlaxoSmithKline, Novartis, Wyeth, and Pfizer, alongside major local formulators (Getz Pharma, Martin Dow, SAMI, CCL, Hilton, Barrett Hodgson, SWISS, Atco, Searle, Surge, Mass Pharma, Bosch Pharma). Revenue is generated through one-time sales of APIs under quote-based pricing with advanced order placement of 1–3 months, customized specifications (bulk density, particle size), flexible payment terms (LC, DD, cheque, telephonic transfer), and doorstep delivery in temperature-controlled vehicles. The head office is at 5-A Zafar Ali Road, Gulberg V, Lahore, with a Karachi liaison office and a single manufacturing site at 34-KM Ferozpur Road near Lahore.

Name

Pharmagen Healthcare Limited

Legal name

Pharmagen Limited

Website

https://pharmagen.com.pk

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

1–10 employees

Short description

Pharmagen Healthcare Limited is Pakistan's largest API manufacturer by value and capacity, producing approximately 1,300 tons per year of 21 antibiotic, anti-diabetic, and anti-inflammatory active pharmaceutical ingredients at dedicated cGMP plants near Lahore for 350+ pharmaceutical formulators including GSK, Novartis, Wyeth, and Pfizer.

Ownership category

akta.pro rank

Product category

Active Pharmaceutical Ingredients (APIs)

NAICS

Pharmaceutical and Medicine Manufacturing (32541)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Generic APIs & Intermediates (Active Ingredients) (HLAIABAG)

akta.pro secondary industry

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Active pharmaceutical ingredients
• API manufacturing
• Bulk drug production
• Antibiotic manufacturing
• Pharmaceutical contract manufacturing

Headquarters

HQ city

Rawalpindi

HQ country

Pakistan

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Active Pharmaceutical Ingredient Sales: Manufacture and sale of Active Pharmaceutical Ingredients (APIs) to pharmaceutical companies. The company produces penicillins, cephalosporins, and general products through dedicated production facilities. Business model based on long-term strategic relationships with customers and suppliers.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Pharmagen manufactures and sells Active Pharmaceutical Ingredients (APIs) through dedicated cGMP-compliant production plants for semi-synthetic penicillins (Amoxicillin, Ampicillin, Cloxacillin, Flucloxacillin), oral and sterile cephalosporins (Cephradine, Cephalexin, Cefixime, Ceftriaxone, Cefotaxime), and a multi-purpose plant producing anti-diabetic, anti-inflammatory, and fluoroquinolone APIs. The company supplies approximately 1,300 tons of APIs per annum to over 350 pharmaceutical manufacturers in Pakistan.

Product overview

Pharmagen Healthcare Limited is Pakistan's leading manufacturer of Active Pharmaceutical Ingredients (APIs), operating as a portfolio of dedicated manufacturing facilities organized into four product divisions: Semi-Synthetic Penicillins (SSPs), Oral Semi-Synthetic Cephalosporins (SSCs), Sterile Semi-Synthetic Cephalosporins, and a Multi-Purpose General Products Plant. The company produces 21 distinct API molecules spanning antibiotic categories (penicillins and cephalosporins), anti-diabetic medications (sitagliptin, empagliflozin, dapagliflozin, vildagliptin), anti-inflammatory/antipyretic drugs (paracetamol, ibuprofen, moxifloxacin), and fluoroquinolone antibiotics (ciprofloxacin). All facilities are cGMP compliant with separate dedicated production plants, and the company serves over 350 customers including multinational pharmaceutical companies such as GlaxoSmithKline, Novartis, and Pfizer/Wyeth, with a combined annual production capacity of approximately 1,300 tons of APIs.

Differentiator

Problem solved

Functional benefit

Products and services

• Amoxicillin Trihydrate Semi-synthetic penicillin antibiotic API used in capsules, oral suspension, and co-amoxiclav tablets. Compacted/micronized form available meeting BP & USP specifications.
• Ampicillin Trihydrate Semi-synthetic penicillin antibiotic API used in capsules, oral suspension, and tablets. Compacted/micronized form available meeting BP & USP specifications.
• Ampicillin Anhydrous Semi-synthetic penicillin antibiotic API in anhydrous form. Compacted/micronized form available meeting BP & USP specifications.
• Cloxacillin Sodium Semi-synthetic penicillin antibiotic API used in capsules and oral suspension. Compacted/micronized form available meeting BP & USP specifications.
• Flucloxacillin Sodium Semi-synthetic penicillin antibiotic API. Compacted/micronized form available meeting BP & USP specifications.
• Cephradine Oral semi-synthetic cephalosporin antibiotic API used in capsules, oral suspension, and tablets. Compacted/micronized form available meeting BP & USP specifications.
• Cephalexin Hydrate Oral semi-synthetic cephalosporin antibiotic API used in capsules, oral suspension, and tablets. Compacted/micronized form available meeting BP & USP specifications.
• Cefixime Oral semi-synthetic cephalosporin antibiotic API used in capsules and oral suspension. Compacted/micronized form available meeting BP & USP specifications.
• Cefadroxil Oral semi-synthetic cephalosporin antibiotic API. Compacted/micronized form available meeting BP & USP specifications.
• Cefaclor Oral semi-synthetic cephalosporin antibiotic API. Compacted/micronized form available meeting BP & USP specifications.
• Cephradine L-Arginine Sterile Sterile semi-synthetic cephalosporin antibiotic API for injectable preparations. Manufactured at sterile facility meeting in-house specifications.
• Ceftriaxone Sodium Broad spectrum sterile semi-synthetic cephalosporin antibiotic API used in injections. Broad spectrum antibiotic/antibacterial agent meeting BP, USP, and EP pharmacopeial standards. CAS No. 104376-79-6.
• Cefotaxime Sodium Sterile semi-synthetic cephalosporin antibiotic API. Manufactured at sterile facility meeting BP & USP specifications.
• Ciprofloxacin HCl General fluoroquinolone antibiotic API manufactured at multi-purpose facility. Meets BP & USP specifications.
• Paracetamol Anti-inflammatory/antipyretic API manufactured at multi-purpose facility. Meets BP & USP specifications.
• Moxifloxacin HCl Fluoroquinolone antibiotic API manufactured at multi-purpose facility. Meets BP & USP specifications.
• Sitagliptin Oral anti-diabetic API (DPP-4 inhibitor) manufactured at multi-purpose facility. Meets in-house specifications.
• Ibuprofen NSAID API manufactured at multi-purpose facility.
• Empagliflozin SGLT2 inhibitor oral anti-diabetic API manufactured at multi-purpose facility. Meets in-house specifications.
• Dapagliflozin SGLT2 inhibitor oral anti-diabetic API manufactured at multi-purpose facility. Meets in-house specifications.
• Vildagliptin Oral anti-diabetic API (DPP-4 inhibitor) manufactured at multi-purpose facility. Meets in-house specifications.

Quantifiable outcome

• Serving over 350+ customers in Pakistan including all major multinational pharmaceutical companies
• +1 more outcomes

Named customers16 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core.

• GlaxoSmithKlinecoreChannel Partner/ Reseller/ DistributorPharmagen is a globally approved and qualified supplier of APIs to GlaxoSmithKline. Long-term strategic business relationship with quality-conscious multinational company.
• NovartiscoreChannel Partner/ Reseller/ DistributorLong-term relationship with Novartis (formerly Sandoz) as API supplier, testifying to Pharmagen's commitment to product quality and customer satisfaction.
• WyethcoreChannel Partner/ Reseller/ DistributorLong-term relationship with Wyeth (formerly Wyeth Laboratories and Cyanamid) as API supplier for their pharmaceutical formulations.
• PfizercoreChannel Partner/ Reseller/ DistributorPfizer/Wyeth is listed as a major customer receiving APIs from Pharmagen Limited.

Scale indicators5 records

Recent moves11 records

Expansion highlights4 records

Regional players

• The Searle Company: Pakistani pharmaceutical manufacturer with broad formulation portfolio. Regional comparable operating in the same domestic market and customer ecosystem as Pharmagen.
• Ferozsons Laboratories: Pakistani pharmaceutical manufacturer with branded formulations and API partnerships. Regional peer that represents the downstream customer base for Pharmagen's APIs in Pakistan.

Direct peers

• Aurobindo Pharma: Indian-headquartered global API and finished dosage manufacturer with deep exposure to semi-synthetic penicillin and cephalosporin APIs. Closest large-scale analog to Pharmagen in product mix and B2B supply model.
• Laurus Labs: Indian API and contract development manufacturer with significant anti-infective and chronic-therapy capabilities. Comparable in scale, GMP posture, and customer mix to Pharmagen.
• Centrient Pharmaceuticals: Dutch-headquartered pure-play beta-lactam (penicillin and cephalosporin) API specialist supplying global generics manufacturers. Directly comparable to Pharmagen's core penicillin and cephalosporin business.
• Ipca Laboratories: Indian API manufacturer with strong presence in anti-infectives and chronic-therapy APIs, supplying both domestic formulation companies and multinationals. Comparable product portfolio and B2B GTM.
• Hikal Limited: Indian manufacturer of active ingredients and intermediates across anti-infectives, pain management, and chronic therapies. Comparable mid-tier API manufacturer serving global generic formulators.

Broad incumbents

• Sandoz (Novartis): Global generics and biosimilars leader with significant captive and merchant API supply. A customer of Pharmagen historically, but also a major in-house API producer with overlapping product lines.
• DSM Sinochem Pharmaceuticals: Global beta-lactam and other API manufacturer (formerly DSM Anti-Infectives) supplying pharmaceutical companies worldwide. A much larger incumbent operating in the same chemistry space.
• North China Pharmaceutical Group: One of China's largest API manufacturers, with strong presence in antibiotics including semi-synthetic penicillins and cephalosporins. A scale incumbent in the same chemistry space.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/PharmagenHealth
• LinkedInlinkedin.com/company/pharmagenlimited

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmagen Healthcare Limited